Dr. Eman Elkadry, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $78,281 | 43 | 70.0% |
| Travel and Lodging | $11,495 | 44 | 10.3% |
| Consulting Fee | $10,630 | 8 | 9.5% |
| Food and Beverage | $8,420 | 248 | 7.5% |
| Unspecified | $2,363 | 1 | 2.1% |
| Education | $638.23 | 12 | 0.6% |
| Gift | $80.30 | 1 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $66,300 | 124 | $0 (2024) |
| Allergan, Inc. | $41,081 | 94 | $0 (2022) |
| COLOPLAST CORP | $1,065 | 13 | $0 (2024) |
| Astellas Pharma US Inc | $876.80 | 38 | $0 (2023) |
| Boston Scientific Corporation | $561.77 | 9 | $0 (2024) |
| Caldera Medical, Inc | $435.48 | 6 | $0 (2023) |
| PFIZER INC. | $417.18 | 27 | $0 (2023) |
| Medtronic USA, Inc. | $317.56 | 19 | $0 (2020) |
| Axonics, Inc. | $251.71 | 4 | $0 (2023) |
| Medtronic, Inc. | $220.37 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,598 | 49 | ABBVIE INC. ($22,956) |
| 2023 | $18,027 | 43 | ABBVIE INC. ($17,144) |
| 2022 | $27,796 | 78 | ABBVIE INC. ($23,258) |
| 2021 | $19,654 | 40 | Allergan, Inc. ($16,666) |
| 2020 | $9,376 | 33 | Allergan, Inc. ($9,077) |
| 2019 | $11,865 | 50 | Allergan Inc. ($11,108) |
| 2018 | $993.05 | 24 | Allergan Inc. ($475.25) |
| 2017 | $597.70 | 40 | Medtronic USA, Inc. ($203.74) |
All Payment Transactions
357 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological) | Consulting Fee | Cash or cash equivalent | $362.50 | General |
| Category: UROLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $30.38 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/12/2024 | Boston Scientific Corporation | Upsylon (Device) | Food and Beverage | In-kind items and services | $157.50 | General |
| Category: Upsylon URO | ||||||
| 11/05/2024 | Boston Scientific Corporation | Solyx SIS System (Device) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Solyx_URO | ||||||
| 10/23/2024 | Boston Scientific Corporation | Solyx SIS System (Device) | Food and Beverage | In-kind items and services | $46.00 | General |
| Category: Solyx_URO | ||||||
| 10/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/18/2024 | COLOPLAST CORP | Altis (Device) | Food and Beverage | In-kind items and services | $93.97 | General |
| Category: Women's Health | ||||||
| 10/02/2024 | COLOPLAST CORP | Altis (Device) | Food and Beverage | In-kind items and services | $63.23 | General |
| Category: Women's Health | ||||||
| 09/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.81 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.79 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/27/2024 | Boston Scientific Corporation | Upsylon (Device) | Food and Beverage | In-kind items and services | $110.04 | General |
| Category: Upsylon_URO | ||||||
| 06/24/2024 | Boston Scientific Corporation | Solyx SIS System (Device) | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: Solyx_URO | ||||||
| 06/04/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: UROLOGY | ||||||
| 05/29/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: UROLOGY | ||||||
| 05/21/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: UROLOGY | ||||||
| 05/14/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $84.65 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 05/03/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $286.20 | General |
| Category: UROLOGY | ||||||
| 05/03/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $222.58 | General |
| Category: UROLOGY | ||||||
| 05/03/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $118.00 | General |
| Category: UROLOGY | ||||||
| 05/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $111.72 | General |
| Category: UROLOGY | ||||||
| 05/03/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $56.95 | General |
| Category: UROLOGY | ||||||
| 05/03/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $41.00 | General |
| Category: UROLOGY | ||||||
| 05/03/2024 | ABBVIE INC. | BOTOX (Biological) | Travel and Lodging | In-kind items and services | $16.97 | General |
| Category: UROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) | AbbVie Inc. | $2,363 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 539 | 5,014 | $221,380 | $63,205 |
| 2022 | 19 | 1,003 | 7,383 | $341,338 | $138,972 |
| 2021 | 24 | 1,007 | 6,108 | $268,321 | $115,465 |
| 2020 | 23 | 1,291 | 4,798 | $324,296 | $115,305 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 16 | 4,400 | $63,298 | $21,655 | 34.2% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2023 | 16 | 25 | $21,424 | $8,882 | 41.5% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Office | 2023 | 21 | 21 | $15,666 | $6,817 | 43.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 37 | $12,959 | $3,718 | 28.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 16 | 17 | $9,666 | $3,550 | 36.7% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 20 | 20 | $9,780 | $3,482 | 35.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 46 | $10,952 | $3,074 | 28.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $7,106 | $2,053 | 28.9% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 19 | 36 | $6,444 | $1,946 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 18 | 18 | $6,859 | $1,488 | 21.7% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Facility | 2023 | 11 | 11 | $13,542 | $1,155 | 8.5% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 92 | 116 | $9,671 | $1,068 | 11.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 24 | $3,592 | $1,003 | 27.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 44 | 50 | $2,250 | $788.09 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 14 | 14 | $3,770 | $751.59 | 19.9% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 20 | 20 | $8,400 | $571.20 | 6.8% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 39 | 43 | $5,677 | $366.59 | 6.5% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Facility | 2023 | 11 | 11 | $6,519 | $366.30 | 5.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 36 | 51 | $539.00 | $173.91 | 32.3% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Facility | 2023 | 11 | 11 | $2,234 | $170.72 | 7.6% |
| 51741 | Electronic assessment of bladder emptying | Facility | 2023 | 24 | 24 | $1,032 | $124.25 | 12.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 22 | 6,090 | $44,153 | $29,317 | 66.4% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Office | 2022 | 45 | 45 | $33,570 | $16,706 | 49.8% |
| 52287 | Exam with injections of chemical for destruction of bladder using an endoscope | Office | 2022 | 21 | 42 | $26,544 | $15,541 | 58.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 115 | $28,391 | $12,797 | 45.1% |
About Dr. Eman Elkadry, MD
Dr. Eman Elkadry, MD is a Urogynecology and Reconstructive Pelvic Surgery healthcare provider based in Cambridge, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033189089.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eman Elkadry, MD has received a total of $111,907 in payments from pharmaceutical and medical device companies, with $23,598 received in 2024. These payments were reported across 357 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($78,281).
As a Medicare-enrolled provider, Elkadry has provided services to 3,840 Medicare beneficiaries, totaling 23,303 services with total Medicare billing of $432,946. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty Urogynecology and Reconstructive Pelvic Surgery
- Location Cambridge, MA
- Active Since 01/24/2006
- Last Updated 05/24/2021
- Taxonomy Code 207VF0040X
- Entity Type Individual
- NPI Number 1033189089
Products in Payments
- BOTOX (Biological) $91,834
- BOTOX (Drug) $11,043
- ALTIS (Device) $549.45
- INTERSTIM (Device) $537.93
- Altis (Device) $515.81
- Desara (Device) $435.48
- PREMARIN (Drug) $335.95
- Myrbetriq (Drug) $322.06
- MYRBETRIQ (Drug) $288.92
- Upsylon (Device) $267.54
- Solyx SIS System (Device) $190.95
- Axonics (Device) $132.07
- BOTOX COSMETIC (Biological) $129.58
- Bulkamid (Device) $119.64
- GEMTESA (Drug) $117.87
- Lupron (Drug) $103.32
- Orilissa (Drug) $86.01
- IMVEXXY (Drug) $71.75
- ADVANTAGE FIT (Device) $58.56
- Endosee (Device) $51.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.